Palmoplantar pustular psoriasis unresponsive to the interleukin-1β antagonist canakinumab.
Division of Dermatology, Baylor University Medical Center, Baylor Scott & White, 3900 Junius Street, Suite 145, Dallas, TX, USA. amderm@gmail.com.
B
B
Mansouri
Division of Dermatology, Baylor University Medical Center, Baylor Scott & White, 3900 Junius Street, Suite 145, Dallas, TX, USA.|Baylor Institute for Immunology Research, Baylor University Medical Center, Baylor Scott & White, 3900 Junius Street, Suite 145, Dallas, TX, USA.
D
D
Kivelevitch
Division of Dermatology, Baylor University Medical Center, Baylor Scott & White, 3900 Junius Street, Suite 145, Dallas, TX, USA.|Department of Pathology, Baylor University Medical Center, Baylor Scott & White, 3900 Junius Street, Suite 145, Dallas, TX, USA.
M
M
Campa
Division of Dermatology, Baylor University Medical Center, Baylor Scott & White, 3900 Junius Street, Suite 145, Dallas, TX, USA.
A
A
Menter
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy*; D006229:Hand Dermatoses / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D053583:Interleukin-1beta; C541220:canakinumab